NCT02274233 · Interventional trial
Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia
Overall registry status Terminated
Phase 1
Conditions Beta-Thalassemia, Iron Overload
Delaware Valley sites
- Sideris Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory